60. BIOS Edition: Investing in biotech and healthcare, Yizhen Dong, Partner, Global Founders Capital
Yizhen is passionate about investing in and working with persevering entrepreneurs who want to change the world, especially in healthcare and biotech. Yizhen focuses on early stage investments in fron...
9 Kesä 202128min
59. Targeted cancer therapies using engineered viruses, Alice Bexon, Chief Medical Officer, Vyriad
Dr. Bexon brings to Vyriad more than 20 years of management experience in clinical development of biopharmaceuticals, including management of multi-site clinical trials and FDA approval of lead assets...
19 Touko 202119min
58. End game vaccine for COVID-19, Marty Moore, Cofounder and CEO, Meissa Vaccines
Martin (Marty) is a cofounder and chief executive officer of Meissa Vaccines. Prior to cofounding Meissa, Marty was an Associate Professor at Emory University and director of the Emory Children’s Cent...
12 Touko 202124min
57. Next frontier in schizophrenia and mental health, Andrew Miller, Founder and COO, Karuna
Dr. Miller is a Founder and the Chief Operating Officer of Karuna Therapeutics. Dr. Miller is the lead inventor of Karuna’s KarXT platform and served as CEO of Karuna from 2016-2018. He served as a me...
5 Touko 202127min
56. Turning cancer on itself, Sam Mazin, Founder and CTO, Thorsten Melcher, CBO, RefleXion
Samuel Mazin, Ph.D. Founder and Chief Technology Officer Member, Board of Directors Sam Mazin, Ph.D., co-founded RefleXion Medical in 2009, where he is the inventor of the company’s core technology. ...
28 Huhti 202127min
55. Gene therapy for hearing loss, Heather Wolff, VP of Clinical Development Operations, Decibel
Heather Wolff joined Decibel in February 2018 as the head of clinical development operations for Decibel Therapeutics. Heather is responsible for Decibel’s clinical operations, regulatory operations, ...
21 Huhti 202121min
54. CRISPR treating cancer, Rachel Haurwitz, Co-founder and CEO, Caribou Biosciences
Rachel is a co-founder of Caribou Biosciences and has been President and CEO since its inception in 2011. Rachel is an inventor on several patents and patent applications covering multiple CRISPR-base...
14 Huhti 202122min
53. Leading a rare disease biopharma company, Paula Ragan, CEO and President, X4 Pharmaceuticals
Dr. Ragan has been X4’s President and Chief Executive Officer and a member of the X4 Board of Directors since July 2014. She has more than 18 years of experience building companies in the biotechnolog...
8 Huhti 202127min
